OTCQB: PHRRF | CSE: PHRM
PharmaTher Holdings Ltd. Ketamine
  • HOME
  • COMPANY
  • PORTFOLIO
    • PHARMAPATCH
    • KetAImine AI
    • KetaVault
    • SAIRIYO
  • INVESTORS
  • NEWS
  • HOME
  • COMPANY
  • PORTFOLIO
    • PHARMAPATCH
    • KetAImine AI
    • KetaVault
    • SAIRIYO
  • INVESTORS
  • NEWS

Unlocking the therapeutic potential of Ketamine, Psychedelics, and GLP-1 Drugs.

About Us

Picture

Our Leadership

Picture

Fabio Chianelli
​Chairman and CEO

Mr. Chianelli has over 25 years of professional and investment experience in specialty life sciences companies. He founded PharmaTher in 2020. He was the Founder and President of Revive Therapeutics Ltd. between 2012 and 2019.
Picture

Dr. Beverly J. Incledon
​Director

Dr. Incledon has over 30 years of experience in the pharmaceutical industry, encompassing novel drug-delivery technologies, drug discovery, and product development. Dr. Incledon was the Executive Vice President, Research & Development of Ironshore Pharmaceuticals, which Collegium acquired for $525 million in 2024.
Picture

Carmelo Marrelli
CFO

Mr. Marrelli holds a Bachelor of Commerce degree from the University of Toronto and is qualified as a Chartered Accountant and as a Certified General Accountant in Canada. Mr. Marrelli has been a principal of Marrelli Support Services Inc., a firm providing accounting and financial administration services to Canadian public companies, since February 2009.
Psychedelic Pharmaceuticals
Contact Us
© COPYRIGHT 2026.  PharmaTher Holdings Ltd.   ALL RIGHTS RESERVED.
"The product candidates described on this website are investigational and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. Safety and efficacy have not been established."